Machine Learning Algorithm May Predict Severity & DMT Costs and Other MS News
Dec 26, 2022, 12:00 AM
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about a machine learning algorithm that uses genetic, clinical, and demographic information to more accurately predict disease severity.
He also reads “MS News Notes: DMT Costs, Copaxone, EBV, Rituximab” by Ed Tobias, from his column “The MS Wire.”
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/